Venture Map · Round
Ability Pharmaceuticals — Other · €2.5M
Announced 2020-03-16 · Cerdanyola del Vallès · Biotech
The EU's EIC Accelerator awarded AbilityPharma €5M in total: a €2.5M grant plus €2.5M in equity from investors selected by the European Investment Bank. The money funds a Phase 2b trial of ABTL0812 with chemotherapy in advanced pancreatic cancer. Existing shareholders include Inveready, Everis and Sodena.
RoundOther
Amount€2.5M
LeadNot disclosed
Date2020-03-16
CityCerdanyola del Vallès
SectorBiotech
The company
Investors 1
EEuropean Investment Bank